Scarica l'app Stockscreener
33.07
6.88%
2.13
Cg Oncology Inc Borsa (CGON) Ultime notizie
is cg oncology inc. still worth holding after the dip2025 Market Trends & High Accuracy Swing Entry Alerts - Newser
Using economic indicators to assess CG Oncology Inc. potentialEarnings Overview Report & Safe Entry Momentum Stock Tips - Newser
CG Oncology Inc. stock trend forecastMarket Risk Analysis & Accurate Entry and Exit Point Alerts - Newser
What are CG Oncology Inc.’s technical support levels2025 Short Interest & Community Verified Swing Trade Signals - خودرو بانک
CG Oncology reports 41.8% complete response rate at 24 months for bladder cancer drug - Investing.com Canada
Understanding CG Oncology Inc.’s price movementQuarterly Profit Report & Technical Entry and Exit Tips - Newser
Will CG Oncology Inc. outperform the marketTrade Analysis Report & Consistent Profit Focused Trading Strategies - Newser
Is CG Oncology Inc. a candidate for recovery playTrade Volume Report & Real-Time Volume Surge Alerts - Newser
Updated BOND-003 data support durability of cretostimogene grenadenorepvec in NMIBC - Urology Times
CG Oncology stock rises on strong bladder cancer treatment durability data - Investing.com Australia
Cg Oncology shares rise 5.20% premarket after announcing positive 24-month complete response rate for cretostimogene. - AInvest
CG Oncology Says Investigational Bladder Cancer Drug Shows 'Robust' Response - MarketScreener
CG Oncology Reports 41.8% Complete Response Rate for Cretostimogene in High-Risk Bladder Cancer Patients Unresponsive to BCG Treatment - Quiver Quantitative
41.8% Complete Response: CG Oncology's Breakthrough Bladder Cancer Drug Shows Best-in-Disease Durability - Stock Titan
Northern Trust Corp Buys 37,904 Shares of CG Oncology, Inc. $CGON - Defense World
Song Hong Fang, CG Oncology director, sells $2.78m in shares - Investing.com Canada
Can CG Oncology Inc. withstand a market correctionJuly 2025 Rallies & Fast Moving Stock Trade Plans - خودرو بانک
Visualizing CG Oncology Inc. stock with heatmapsPortfolio Gains Report & Real-Time Volume Spike Alerts - Newser
Chart based exit strategy for CG Oncology Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
Detecting support and resistance levels for CG Oncology Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
CG Oncology Directors Sell Shares, Buy Others Amid Market Volatility. - AInvest
How does CG Oncology Inc. score in quality rankingsEarnings Growth Summary & Daily Chart Pattern Signal Reports - خودرو بانک
Risk On: Can CG Oncology Inc. deliver alphaJuly 2025 Volume & Daily Chart Pattern Signals - خودرو بانک
What moving averages say about CG Oncology Inc.July 2025 Final Week & Free Expert Approved Momentum Trade Ideas - Newser
Will CG Oncology Inc. stock go up soonShort Setup & Real-Time Volume Triggers - Newser
Real time breakdown of CG Oncology Inc. stock performance - Newser
CG Oncology Inc. stock chart pattern explained2025 Biggest Moves & Long-Term Investment Growth Plans - Newser
Ani Pharmaceuticals shares rise 1.98% after-hours following CG Oncology's PIVOT-006 study enrollment completion. - AInvest
Will CG Oncology Inc. benefit from macro trendsSwing Trade & Accurate Intraday Trading Signals - Newser
CG Oncology Completes Enrollment for Phase 3 Study - Orange County Business Journal
CG Oncology completes enrollment for bladder cancer therapy trial - Investing.com
CG Oncology completes enrollment in PIVOT-006 - TipRanks
CG Oncology Completes Rapid Enrollment in Phase 3 Study for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - Quiver Quantitative
CG Oncology Completes Enrollment in PIVOT-006 Trial for Intermediate-Risk Non-Muscle Invasive Bladder Cancer - AInvest
Largest-Ever Trial: 360 Patients Join CG Oncology's Breakthrough Bladder Cancer Study One Year Early - Stock Titan
Real time alert setup for CG Oncology Inc. performanceJuly 2025 Momentum & Daily Profit Focused Screening - Newser
Developing predictive dashboards with CG Oncology Inc. data2025 Retail Activity & Real-Time Volume Triggers - Newser
How to build a custom watchlist for CG Oncology Inc.Market Movement Recap & Community Supported Trade Ideas - Newser
Analyzing CG Oncology Inc. with risk reward ratio chartsTrade Performance Summary & AI Powered Buy/Sell Recommendations - Newser
Should you hold or exit CG Oncology Inc. nowEntry Point & Free Verified High Yield Trade Plans - Newser
Published on: 2025-09-03 00:18:12 - Newser
Can CG Oncology Inc. sustain earnings growthWeekly Earnings Recap & Long-Term Safe Investment Plans - خودرو بانک
Is CG Oncology Inc. stock reversal real or fakeBear Alert & Low Risk High Reward Trade Ideas - Newser
Technical signs of recovery in CG Oncology Inc.Quarterly Portfolio Review & Free Low Drawdown Momentum Trade Ideas - Newser
Using flow based indicators on CG Oncology Inc.2025 Price Momentum & Consistent Growth Stock Picks - Newser
Is CG Oncology Inc. still worth holding after the dipQuarterly Performance Summary & Verified Chart Pattern Trade Signals - Newser
Can CG Oncology Inc. deliver alphaJuly 2025 Market Mood & Breakout Confirmation Trade Signals - خودرو بانک
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):